Studies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa

2011 ◽  
Vol 17 (11) ◽  
pp. 751-755 ◽  
Author(s):  
Frances L. Chadbourne ◽  
Catriona Raleigh ◽  
Hayder Z. Ali ◽  
Paul W. Denny ◽  
Steven L. Cobb
Keyword(s):  
Antimicrobial Peptides ◽  
Temporin A

Antimicrobial peptides (Temporin A and Iseganan IB-367): Effect on the cysticerci of Taenia crassiceps

2009 ◽  
Vol 164 (2) ◽  
pp. 126-130 ◽  
Author(s):  
Abraham Landa ◽  
Lucía Jiménez ◽  
Kaethe Willms ◽  
Luis Felipe Jiménez-García ◽  
Reyna Lara-Martínez ◽  
...  
Keyword(s):  
Antimicrobial Peptides ◽  
Taenia Crassiceps ◽  
Temporin A

scholarly journals A Novel Delivery System for the Controlled Release~of Antimicrobial Peptides: Citropin 1.1 and Temporin A

Polymers ◽  
2018 ◽  
Vol 10 (5) ◽  
pp. 489 ◽  
Author(s):  
Urszula Piotrowska ◽  
Ewa Oledzka ◽  
Anna Zgadzaj ◽  
Marta Bauer ◽  
Marcin Sobczak
Keyword(s):  
Controlled Release ◽  
Antimicrobial Peptides ◽  
Delivery System ◽  
Citropin 1.1 ◽  
Temporin A

scholarly journals Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Wioletta Baranska-Rybak ◽  
Oscar Cirioni ◽  
Malgorzata Dawgul ◽  
Malgorzata Sokolowska-Wojdylo ◽  
Lukasz Naumiuk ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Antimicrobial Peptides ◽  
Therapeutic Implication ◽  
Human Diseases ◽  
High Efficacy ◽  
Opposite Situation ◽  
Conventional Antibiotics ◽  
Aurein 1.2 ◽  
Citropin 1.1 ◽  
Temporin A

Superantigens are proteins comprising a group of molecules produced by various microorganisms. They are involved in pathogenesis of several human diseases. The aim of the study was the comparison of susceptibility to antibiotics and antimicrobial peptides (AMPs) of Staphylococcus aureus (SA) strains producing staphylococcal enterotoxins SEA, SEB, SEC, SED, and TSST-1 and nonproducing ones. In the group of the total 28 of the patients with erythrodermia the presence of SA was confirmed in 24 cases. The total of 14 strains of SA excreted enterotoxins SEA, SEC, SED, and TSST-1. We did not observe that strains producing mentioned superantigens were less susceptible to AMPs (aurein 1.2, citropin 1.1, lipopeptide, protegrin 1, tachyplesin 3, temporin A, and uperin 3.6). The opposite situation was observed in conventional antibiotics. SA strains excreting tested superantigens had higher MICs and MBCs than nonproducing ones. The interesting finding considering the high efficacy of AMPs, against all examined strains of SA, makes them attractive candidates for therapeutic implication.

scholarly journals Temporin A and Related Frog Antimicrobial Peptides Use Formyl Peptide Receptor-Like 1 as a Receptor to Chemoattract Phagocytes

2004 ◽  
Vol 173 (4) ◽  
pp. 2652-2659 ◽  
Author(s):  
Qian Chen ◽  
David Wade ◽  
Kahori Kurosaka ◽  
Zhao Yuan Wang ◽  
Joost J. Oppenheim ◽  
...  
Keyword(s):  
Antimicrobial Peptides ◽  
Formyl Peptide Receptor ◽  
Peptide Receptor ◽  
Formyl Peptide ◽  
Temporin A

Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA)

2019 ◽  
Vol 18 (24) ◽  
pp. 2116-2126 ◽  
Author(s):  
Eleonora Ciandrini ◽  
Gianluca Morroni ◽  
Daniela Arzeni ◽  
Wojciech Kamysz ◽  
Damian Neubauer ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Antimicrobial Activity ◽  
Antimicrobial Peptides ◽  
Growth Inhibition ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Clinical Isolates ◽  
Methicillin Resistant ◽  
Time Kill ◽  
Citropin 1.1 ◽  
Temporin A

Background: Antimicrobial research is being focused to look for more effective therapeutics against antibiotic-resistant infections caused by methicillin-resistant Staphylococcus aureus (MRSA). In this direction, antimicrobial peptides (AMP) appear as promising tool. Objectives: This study evaluated the antimicrobial activity of different AMPs (Citropin 1.1, Temporin A, Pexiganan, CA(1–7)M(2–9)NH2, Pal-KGK-NH2, Pal-KKKK-NH2, LL-37) against human MRSA clinical isolates. Methods: The Minimum Inhibitory Concentration (MIC) was assessed for each AMP; then, the most active ones (Citropin 1.1, Temporin A, CA(1–7)M(2–9)NH2 and Pal-KGK-NH2) were tested against selected MRSA strains by time-kill studies. Results: The lowest MIC value was observed for Pal-KGK-NH2 (1 µg/ml), followed by Temporin A (4- 16 µg/ml), CA(1–7)M(2–9)NH2 (8-16 µg/ml) and Citropin 1.1 (16-64 µg/ml), while higher MICs were evidenced for LL-37, Pexiganan and Pal-KKKK-NH2 (> 128 µg/ml). In time-kill experiments, Citropin 1.1 and CA(1-7)M(2-9)NH2 showed a relatively high percentage of growth inhibition (>30 %) for all the tested MRSA clinical isolates, with a dose-dependent activity resulting in the highest percentage of bacterial growth inhibition (89.39%) at 2MIC concentration. Conclusion: Overall, our data demonstrated the potential of some AMPs against MRSA isolates, such as Citropin 1.1 and CA(1-7)M(2-9)NH2, that represents a promising area of development for different clinical applications.

Antimicrobial peptides in COPD

Pneumologie ◽  
2009 ◽  
Vol 63 (S 01) ◽  
Author(s):  
G Günther ◽  
E Andresen ◽  
J Bullwinkel ◽  
C Lange ◽  
H Heine
Keyword(s):  
Antimicrobial Peptides
Sign in / Sign up

Export Citation Format

Share Document